A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma Journal Article


Authors: Qualls, D.; Lam, H. Y.; Whiting, K.; Kumar, A.; Matasar, M.; Owens, C.; Nichols, C.; Espeleta, J. A.; Qiu, A.; Subzwari, S.; Biggar, E.; Seshan, V.; Salles, G.; Younes, A.; Batlevi, C.
Article Title: A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma
Journal Title: Blood Advances
Volume: 6
Issue: 18
ISSN: 2473-9529
Publisher: American Society of Hematology  
Date Published: 2022-09-27
Start Page: 5262
End Page: 5266
Language: English
DOI: 10.1182/bloodadvances.2021006555
PUBMED: 35171976
PROVIDER: scopus
PMCID: PMC9631700
DOI/URL:
Notes: Letter -- Export Date: 1 November 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Venkatraman Ennapadam Seshan
    382 Seshan
  2. Matthew J Matasar
    289 Matasar
  3. Anita Kumar
    180 Kumar
  4. Connie Wing-Ching Lee Batlevi
    176 Batlevi
  5. Anas Younes
    319 Younes
  6. Colette Ngozi Owens
    66 Owens
  7. Annie Qiu
    7 Qiu
  8. Erin Biggar
    6 Biggar
  9. Karissa A. Whiting
    47 Whiting
  10. Gilles Andre Salles
    269 Salles
  11. David Augustus Qualls
    20 Qualls
  12. Chelsea Lynn Nichols
    15 Nichols
  13. Hiu Ying Julia Lam
    1 Lam